Shonan Kamakura Advanced Medical Center Begins Treatment with Hitachi's First Dedicated Compact Proton Therapy System
TOKYO, Feb 02, 2022 - (JCN Newswire) - Hitachi, Ltd. (TSE: 6501) has announced that "Shonan Kamakura Advanced Medical Center" at Shonan Kamakura General Hospital of Tokushukai Medical Group, where Hitachi's compact proton therapy system (hereafter, "the system") has been installed, has commenced treatment with the system on 31 January 2022. This is the first order for Hitachi's dedicated compact proton therapy system.
![](http://www.jcnnewswire.com/topimg/Low_ProtonTherapySystem.jpg) | Proton Therapy System |
Shonan Kamakura Advanced Medical Center is a medical facility providing comprehensive cancer treatment, including advanced radiotherapy, built adjacent to the site of Shonan Kamakura General Hospital by Tokushukai Group Medical Corporation, which operates approximately 400 medical facilities and nursing homes throughout Japan. Until now, there have been no proton therapy facilities in Kanagawa Prefecture, where the center is located, but the compact proton therapy system, with its reduced footprint, makes it possible to install a proton therapy facility on a limited site close to the city center.
Features of the installed system
In response to the growing worldwide demand for smaller proton therapy systems, Hitachi has developed the proton therapy system, which is specifically designed for a single treatment room. The system is a compact proton therapy system which, by optimizing the layout of the machine, reduces the installation area to about 70% of that of conventional solutions, making it possible to install the system on a limited site in an urban area and reducing the cost and time involved in its installation. It is equipped with advanced technologies such as spot scanning irradiation technology, which allows the proton beam to be delivered according to the shape of the cancer, a 360degree rotating gantry with cone-beam CT(1) for high-precision positioning, and Real-time image Gated Proton Therapy (RGPT)(2), making it both compact and highly functional.
Hitachi is committed to accelerating the global development of particle therapy system and contributing to cancer treatment around the world, as well as to further expanding its healthcare services.
(1) Cone beam CT provides three-dimensional anatomical images of patients, at isocenter immediately prior to being treated. Information on the location of bone is obtained from traditional orthogonal x-rays and the motion of tumors is captured by RGPT. These are then combined with the ability to identify healthy tissue surrounding a tumor, particularly the location and shape of soft tissue, via Cone beam CT. (2) RGPT allows real-time beam irradiation to the tumor while compensating for movement associated with respiration. This technology was collaboratively developed between Hokkaido University and Hitachi, and supported by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST) of the Japan Society for the Promotion of Science.
Overview of Particle Therapy
Particle Therapy is an advanced type of cancer radiotherapy. Protons extracted from hydrogen atoms, or carbon ions are accelerated up to 70% of the speed of light. This energy is concentrated directly on the tumor while minimizing radiation dose to surrounding healthy tissue. Particle therapy improves the quality of life for cancer patients since the patient experiences no pain during treatment and the procedure has very few side effects compared to that of traditional radiotherapy. In most cases, patients can continue with their normal daily activities while undergoing treatment.
About Hitachi, Ltd.
Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, contributes to a sustainable society with a higher quality of life by driving innovation through data and technology as the Social Innovation Business. Hitachi is focused on strengthening its contribution to the Environment, the Resilience of business and social infrastructure as well as comprehensive programs to enhance Security & Safety. Hitachi resolves the issues faced by customers and society across six domains: IT, Energy, Mobility, Industry, Smart Life and Automotive Systems through its proprietary Lumada solutions. The company's consolidated revenues for fiscal year 2020 (ended March 31, 2021) totaled 8,729.1 billion yen ($78.6 billion), with 871 consolidated subsidiaries and approximately 350,000 employees worldwide. For more information on Hitachi, please visit the company's website at https://www.hitachi.com.
Source: Hitachi, Ltd. Sectors: MedTech
Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
|
Latest Release
![NTT DOCOMO](http://www.jcnnewswire.com/image/toppage/Docomo_Top.jpg) DOCOMO and NTT Com Jointly Demonstrate Practicality of DOCOMO's New Multi-platform Cloud-rendering Technology Jul 26, 2024 17:05 JST
| ![Tanaka Holdings Co., Ltd.](http://www.jcnnewswire.com/image/toppage/Tanaka_Logo_2s.jpg) TANAKA Precious Metals Provided Award Items and Ceremony Souvenirs for the International Friendly Matches of the Japan Men's National Blind Football Team at the "DAICEL Blind Football Japan Cup 2024 in Osaka" on July 7 Jul 26, 2024 03:00 JST
| ![Eisai](http://www.jcnnewswire.com/image/toppage/eisai45.jpg) Eisai and EcoNaviSta Enter into Business Alliance Agreement Aimed at Building a Dementia Ecosystem and Commence Collaboration Jul 25, 2024 10:30 JST
| ![Hitachi, Ltd.](http://www.jcnnewswire.com/image/toppage/hitachi.jpg) Hitachi Awarded Largest Contract in Singapore to Supply 450 Lifts at HDB Blocks Jul 24, 2024 16:27 JST
| ![Hitachi, Ltd.](http://www.jcnnewswire.com/image/toppage/hitachi.jpg) Hitachi to Announce Capital Reorganization of Air Conditioning Joint Venture Jul 24, 2024 15:02 JST
| ![Eisai](http://www.jcnnewswire.com/image/toppage/eisai45.jpg) Eisai to Present Dual-Acting Lecanemab Three-Year Efficacy and Safety Data and Discuss Long-Term Outcomes of Continued Treatment at the Alzheimer's Association International Conference 2024 Jul 23, 2024 20:23 JST
| ![Fujitsu Ltd](http://www.jcnnewswire.com/image/toppage/Fujitsu.Logo.68.jpg) Toyota Material Handling Japan and Fujitsu launch Japan's first service for evaluating forklift safety in the cloud using AI Jul 23, 2024 11:26 JST
| ![Toyota Motor Corporation](http://www.jcnnewswire.com/image/toppage/ToyotaBb.68.jpg) AEON and CJPT working to resolve logistics industry issues and achieve carbon neutrality at AEON Fukuoka XD Jul 22, 2024 13:52 JST
| ![Toyota Motor Corporation](http://www.jcnnewswire.com/image/toppage/ToyotaBb.68.jpg) Rovanpera and Ogier score another TOYOTA GAZOO Racing one-two Jul 22, 2024 12:30 JST
| ![Honda Motor Co, Ltd](http://www.jcnnewswire.com/image/toppage/honda.gif) Team HRC with Japan Post Wins 45th Suzuka 8 Hours Endurance Road Race Jul 22, 2024 11:33 JST
| ![Honda Motor Co, Ltd](http://www.jcnnewswire.com/image/toppage/honda.gif) Honda to Hold its Official e-Motorsports Event, "Honda Racing eMS 2024" Jul 19, 2024 20:04 JST
| ![Mitsubishi Heavy Industries, Ltd.](http://www.jcnnewswire.com/image/toppage/MHI_newT.jpg) MHI America Acquires Three Utility-Scale Solar Power Projects in Pennsylvania, Advancing the Company's Energy Transition Strategy Jul 19, 2024 19:04 JST
| ![JCB](http://www.jcnnewswire.com/image/toppage/JCB55.jpg) JCB and Worldline unveil a new whitepaper offering European merchants invaluable insights into facilitating seamless payments for international consumers Jul 19, 2024 12:00 JST
| ![Fujitsu Ltd](http://www.jcnnewswire.com/image/toppage/Fujitsu.Logo.68.jpg) Fujitsu Chosen to Help Solving Social Issues Caused by Fake News Jul 19, 2024 11:30 JST
| ![Champion REIT](http://www.jcnnewswire.com/image/toppage/ChampionREIT1_Top.jpg) Champion REIT holds first 'ESG Week' Jul 18, 2024 20:14 JST
| ![Lexus International](http://www.jcnnewswire.com/image/toppage/Lexus_68.jpg) Lexus LBX Adds a New High Performance Variant, the LBX "MORIZO RR" Jul 18, 2024 17:25 JST
| ![NEC Corporation](http://www.jcnnewswire.com/image/toppage/NEC.62.jpg) VitalLife and Bumrungrad International Hospital in Thailand Launch NEC's FonesVisuas Test: First Major Deployment Outside Japan, Revolutionizing Disease Risk Prediction Jul 18, 2024 15:34 JST
| ![Fujitsu Ltd](http://www.jcnnewswire.com/image/toppage/Fujitsu.Logo.68.jpg) Fujitsu publishes CHRO Roundtable Report 2024, summarizing the challenges and implications of the implementation of data-driven human capital management Jul 18, 2024 10:44 JST
| ![Fujitsu Ltd](http://www.jcnnewswire.com/image/toppage/Fujitsu.Logo.68.jpg) Fujitsu-sponsored professional golfer Ayaka Furue victorious in the Amundi Evian Championship Jul 16, 2024 23:26 JST
| ![Mitsubishi Corporation](http://www.jcnnewswire.com/image/toppage/MC.68.jpg) Neste and Mitsubishi Corporation agree on strategic partnership to develop supply chains for renewable chemicals and plastics Jul 16, 2024 18:36 JST
|
More Latest Release >>
|